Invention Grant
US09181248B2 [1,2,4]triazolopyridines and their use as phosphodiesterase inhibitors
有权
[1,2,4]三唑并吡啶类及其作为磷酸二酯酶抑制剂的用途
![[1,2,4]triazolopyridines and their use as phosphodiesterase inhibitors](/docs/US/2015-11-10/US09181248B2/abs.jpg.600x600.jpg)
- Patent Title: [1,2,4]triazolopyridines and their use as phosphodiesterase inhibitors
- Patent Title (中): [1,2,4]三唑并吡啶类及其作为磷酸二酯酶抑制剂的用途
-
Application No.: US14572218Application Date: 2014-12-16
-
Publication No.: US09181248B2Publication Date: 2015-11-10
- Inventor: Simon Feldbaek Nielsen , Jens Christian Hojland Larsen
- Applicant: LEO Pharma A/S
- Applicant Address: DK Ballerup
- Assignee: LEO PHARMA A/S
- Current Assignee: LEO PHARMA A/S
- Current Assignee Address: DK Ballerup
- Agency: Birch Stewart Kolasch & Birch, LLP
- Main IPC: A61K31/437
- IPC: A61K31/437 ; C07D471/04
![[1,2,4]triazolopyridines and their use as phosphodiesterase inhibitors](/abs-image/US/2015/11/10/US09181248B2/abs.jpg.150x150.jpg)
Abstract:
The present invention relates to novel [1,2,4]triazolopyridine compounds with phosphodiesterase inhibitory activity, as well as to their use as therapeutic agents in the treatment of inflammatory diseases and conditions.
Public/Granted literature
- US20150105420A1 [1,2,4]TRIAZOLOPYRIDINES AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS Public/Granted day:2015-04-16
Information query
IPC分类:
